Amit Hazan

Stock Analyst at Goldman Sachs

(2.08)
# 3,024
Out of 5,045 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return

Stocks Rated by Amit Hazan

Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $73.07
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13$2.5
Current: $6.77
Upside: -63.07%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22$19
Current: $1.41
Upside: +1,247.52%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9$8
Current: $16.34
Upside: -51.04%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73$63
Current: $52.79
Upside: +19.34%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319$272
Current: $179.38
Upside: +51.63%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19$17
Current: $15.14
Upside: +12.29%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510$435
Current: $12.63
Upside: +3,344.18%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39$44
Current: $34.38
Upside: +27.98%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97$73
Current: $83.48
Upside: -12.55%
Maintains: Sell
Price Target: $60$53
Current: $19.16
Upside: +176.62%
Initiates: Buy
Price Target: $57
Current: $30.69
Upside: +85.73%
Maintains: Neutral
Price Target: $11$9.5
Current: $16.33
Upside: -41.82%
Maintains: Sell
Price Target: $111$104
Current: $124.67
Upside: -16.58%
Maintains: Neutral
Price Target: $80$60
Current: $12.44
Upside: +382.32%
Maintains: Neutral
Price Target: $129$115
Current: $90.97
Upside: +26.42%
Downgrades: Sell
Price Target: $248$150
Current: $368.98
Upside: -59.35%
Initiates: Neutral
Price Target: $46
Current: $100.57
Upside: -54.26%
Initiates: Buy
Price Target: $242
Current: $530.02
Upside: -54.40%
Initiates: Buy
Price Target: $177
Current: $99.56
Upside: +77.78%
Maintains: Neutral
Price Target: $139$147
Current: $189.05
Upside: -22.24%
Upgrades: Neutral
Price Target: $3.5$3.9
Current: $1.38
Upside: +182.61%